We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Jerry Spivak

Jerry L Spivak MD, MACP

Professor of Medicine and Oncology, Director, the Johns Hopkins Center for the Chronic Myeloproliferative Disorders, Johns Hopkins Medical Institution, Baltimore, MD

Jerry L. Spivak, MD, MACP, is a Professor of Medicine and Oncology at the Johns Hopkins University School of Medicine and a member of the active staff of the Johns Hopkins Hospital. Dr. Spivak is a graduate of Cornell University Medical College and received training in internal medicine, hematology and oncology at the Johns Hopkins Hospital, New York Hospital and the National Cancer Institute. Board certified in Internal Medicine and Hematology, Dr. Spivak was Director of the Hematology Division at Johns Hopkins from 1980 to 1992. He is currently the Director of the Johns Hopkins Center for The Chronic

Myeloproliferative Disorders. An author of 266 clinical and scientific publications, the recipient of a Research Career Development Award and a Merit Award from the National Institutes of Health, Dr. Spivak’s research and clinical interests involve the pathogenesis, diagnosis and management of the chronic myeloproliferative disorders, polycythemia vera, primary myelofibrosis, essential thrombocytosis, and, in particular, hematopoietic stem cell behavior in these disorders. His laboratory has expertise in the areas of cell biology, protein chemistry and molecular biology with a special focus on mouse and human hematopoietic stem cell behavior in vitro and in vivo using animal models as surrogates for human disease.